Pharmaceutical licenses for countries with public health problems

This procedure concerns the granting of licences for pharmaceutical products. It aims to ensure access to medicines in countries facing significant public health challenges, potentially by streamlining regulatory processes or facilitating distribution.

It affects pharmaceutical companies and patients in countries with public health problems. The goal is to improve the availability of essential medicines and address specific health crises.